Insulin-resistant diabetes

Details Insulin-resistant diabetes Insulin-resistant diabetes

A - Human Necessities

61

K

A61K 38/30 (2006.01)

Patent

CA 2066227

2066227 9103253 PCTABS00003 Insulin-like growth factor (IGF) is used for treatment of type A insulin-resistant diabetes by reduction of glucose levels. The treatment is applicable to Mendenhall's Syndrome, Werner Syndrome, leprechaunism, lipoatrophic diabetes, and other lipoatrophies.

Affiliated with

Also associated with

Rating

Insulin-resistant diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Insulin-resistant diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin-resistant diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1373634